According to Natco Pharma 's latest financial reports and stock price the company's current Operating Margin is 21.21%. At the end of 2022 the company had an Operating Margin of 10.61%.
Year | Operating Margin | Change |
---|---|---|
2022 | 10.61% | -69.04% |
2021 | 34.29% | 13.82% |
2020 | 30.13% | -24.69% |
2019 | 40.00% | -2.77% |
2018 | 41.14% | 34.39% |
2017 | 30.61% | 66.64% |
2016 | 18.37% | 12.04% |
2015 | 16.40% | -7.11% |
2014 | 17.65% | 12.13% |
2013 | 15.74% | 2.91% |
2012 | 15.30% | 2.73% |
2011 | 14.89% | 1.55% |
2010 | 14.66% | 13.43% |
2009 | 12.93% | -23.42% |
2008 | 16.88% | 2.45% |
2007 | 16.48% | 1.75% |
2006 | 16.19% | 3234.78% |
2005 | 0.49% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.